在治疗高级上腺皮层癌的当前状态和未来方向
Chulkue Pak1, Shinkyo Yoon1, Jae Lyun Lee1
1Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.
Current oncology reports
|February 21, 2024
概括
上皮层癌 (ACC) 治疗正在发展,有针对性的疗法和免疫疗法对晚期疾病有希望. 目前正在进行的研究重点是组合治疗方案,以改善这种具有挑战性的癌症的治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮上腺癌 (ACC) 是一种罕见且具有攻击性的内分泌恶性瘤.
- 晚期ACC的有效治疗选择仍然有限,这构成了重大的临床挑战.
研究的目的:
- 审查当前对上腺皮层癌治疗的理解和发展.
- 专注于疾病晚期的治疗策略.
主要方法:
- 在ACC.中对基因组景观研究的综合文献综述.
- 对针对性疗法和免疫疗法的正在进行的临床试验的分析.
- 综合治疗方案的评估.
主要成果:
- 在ACC的基因组研究已经确定了潜在的治疗点.
- 虽然IGF-1受体抑制剂显示出有限的成功,但VEFGR氨酸激酶抑制剂和免疫检查点抑制剂正在研究中.
- 组合疗法,如伦瓦提尼布与潘布罗利祖马布和卡博赞提尼布与阿特佐利祖马布,正在临床试验中.
- 目前,EDP-M是前线治疗,但仍在寻找有效的二线选择.
结论:
- ACC仍然是一个难以治疗的恶性瘤.
- 向疗法和免疫疗法,特别是在组合中,显示出改善ACC治疗的潜力.
- 进一步的研究至关重要,以建立有效的治疗方案,基于不断发展的基因组理解ACC.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
01:21Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367